和田地区维吾尔族早发急性冠状动脉综合征危险因素研究

周世英, 牛伟华, 安玉楠, 等. 和田地区维吾尔族早发急性冠状动脉综合征危险因素研究[J]. 临床心血管病杂志, 2021, 37(7): 610-615. doi: 10.13201/j.issn.1001-1439.2021.07.005
引用本文: 周世英, 牛伟华, 安玉楠, 等. 和田地区维吾尔族早发急性冠状动脉综合征危险因素研究[J]. 临床心血管病杂志, 2021, 37(7): 610-615. doi: 10.13201/j.issn.1001-1439.2021.07.005
ZHOU Shiying, NIU Weihua, AN Yunan, et al. Risk factors of early-onset acute coronary syndrome in Uygur nationality in Hotan district[J]. J Clin Cardiol, 2021, 37(7): 610-615. doi: 10.13201/j.issn.1001-1439.2021.07.005
Citation: ZHOU Shiying, NIU Weihua, AN Yunan, et al. Risk factors of early-onset acute coronary syndrome in Uygur nationality in Hotan district[J]. J Clin Cardiol, 2021, 37(7): 610-615. doi: 10.13201/j.issn.1001-1439.2021.07.005

和田地区维吾尔族早发急性冠状动脉综合征危险因素研究

  • 基金项目:

    国家自然科学基金项目(No:81970303)

详细信息
    通讯作者: 卢成志,E-mail:lucz8@126.com
  • 中图分类号: R541.4

Risk factors of early-onset acute coronary syndrome in Uygur nationality in Hotan district

More Information
  • 目的:探讨新疆和田维吾尔族早发急性冠状动脉综合征(ACS)患者的临床特点及危险因素。方法:收集2017—2020年在新疆和田地区人民医院心内科住院的维吾尔族早发ACS患者264例(男性年龄≤45岁,女性≤55岁),同时收集同期的非早发ACS患者254例(男性年龄>55岁,女性>65岁),比较两组患者的临床基本特征、发病类型、冠状动脉(冠脉)造影特点。结果:①两组早发ACS均以男性为主,但早发ACS组患者女性比例(78/264,29.5%)显著高于非早发组(25/254,9.8%)(P<0.05)。早发组的体质指数、吸烟史、饮酒史、冠心病家族史以及合并有高血压的比例明显高于非早发组(P<0.05);非早发组合并有糖尿病、脑梗死病史的比例高于早发组(P<0.05);②早发组中血小板计数、甘油三酯、同型半胱氨酸的水平高于非早发组(P<0.05);非早发组中红细胞分布宽度、高密度脂蛋白胆固醇高于早发组(P<0.05);③发病类型上非早发ACS中心肌梗死的比例比早发ACS中更高,早发ACS中不稳定型心绞痛的比例比非早发ACS高(P<0.05);④早发ACS以单支病变为主,非早发ACS以3支病变为主;非早发ACS左主干、前降支、回旋支、右冠所占的比例均高于早发ACS(P<0.05)。⑤多因素logistic回归分析显示,吸烟、冠心病家族史、体质指数、血小板计数高、高密度脂蛋白胆固醇、高同型半胱氨酸是早发ACS的主要危险因素。结论:超重、吸烟、冠心病家族史、高同型半胱氨酸、血小板计数增高、高密度脂蛋白胆固醇是和田地区维吾尔族早发ACS的主要危险因素,冠脉血管病变特点上早发ACS患者以单支病变为主,非早发ACS以3支病变为主。
  • 加载中
  • [1]

    Herath HMM,Weerasinghe NP,Weerarathna TP,et al.A comparison of the prevalence of the metabolic syndrome among Sri Lankan patients with type 2 diabetes mellitus using WHO,NCEP-ATP Ⅲ,and IDF defifinitions[J].Int J Chronic Dis,2018,2018:7813537.

    [2]

    杨晓,谢勇,徐日新,等.血浆致动脉硬化指数对早发冠心病的预测作用[J].临床心血管病杂志,2020,36(11):1000-1003.

    [3]

    Sheikhvatan M,Boroumand MA,Behmanesh M,et al.Integrin beta-3 gene polymorphism and risk for myocardial infarction in premature coronary disease[J].Iran J Biotechnol,2019,17(2):e1921.

    [4]

    中国医师协会急诊医师分会.急性冠脉综合征急诊快速诊治指南(2019).中华急诊医学杂志,2019,10(4):421-428.

    [5]

    高血压联盟.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.

    [6]

    中华医学会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.

    [7]

    彭斌,吴波.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.

    [8]

    胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.

    [9]

    Ansari WM,Humphries SE,Naveed AK,et al.Effect of coronary artery disease risk SNPs on serum cytokine levels and cytokine imbalance in premature coronary artery disease[J].Cytokine,2019,122:154060.

    [10]

    孙莹,韩雅玲,李毅,等.吸烟、超重及肥胖对女性早发冠心病影响[J].临床军医杂志,2019,47(10):1041-1043.

    [11]

    Simons LA,Simons J,Friedlander Y,et al.LDL-cholesterol predicts a first CHD event in senior citizens,especially so in those with elevated lipoprotein(a):Dubbo Study of the Elderly[J].Heart Lung Circ,2018,27(3):386-389.

    [12]

    Bom MJ,van der Heijden DJ,Kedhi E,et al.Early detection and treatment of the vulnerable coronary plaque:can we prevent acute coronary syndromes?[J].Circ Cardiovasc Imaging,2017,10(5):100.

    [13]

    Sumarjaya I,Nadha I,Lestari A.High lipoprotein(a)levels as a predictor of major adverse cardiovascular events in hospitalized-acute myocardial infarction patients[J].Vasc Health Risk Manag,2020,16:125-132.

    [14]

    Silverman MG,Ference BA,Im K,et al.Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions:a systematic review and Meta-analysis[J].JAMA,2016,316(12):1289-1297.

    [15]

    Reiner Ž.Hypertriglyceridaemia and risk of coronary artery disease[J].Nat Rev Cardiol,2017,14(7):401-411.

    [16]

    Bosevski M,Zlatanovikj N,Petkoska D,et al.Plasma homocysteine in patients with coronary and carotid artery disease:a case control study[J].Pril(Makedon Akad Nauk Umet Odd Med Nauki),2020,41(1):15-22.

    [17]

    Verdoia M,Rolla R,Negro F,et al.Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor[J].Nutr Metab Cardiovasc Dis,2020,30(2):292-299.

    [18]

    Parikh NS,Salehi Omran S,Kamel H,et al.Symptoms of depression and active smoking among survivors of stroke and myocardial infarction:An NHANES analysis[J].Prev Med,2020,137:106131.

    [19]

    Naser SY,Ragab R,Mohamed IH,et al.Acute myocardial infarction in libyan patients below 45 years of age:Prevalence and risk factors[J].Libyan J Med Sci,2020,4(1):100.

    [20]

    Schlyter M,Leosdottir M,Engström G,et al.Smoking cessation after acute myocardial infarction in relation to depression and personality factors[J].Int J Behav Med,2016,23(2):234-242.

    [21]

    Tian X,Zuo Y,Chen S,et al.Associations between changes in serum uric acid and the risk of myocardial infarction[J].Int J Cardiol,2020,314:25-31.

    [22]

    Yang Y,Lin LH,Gao M,et al.Association between the serum uric acid level and the severity of coronary artery disease in a retrospective study of China Nondialysis CKD Patients[J].Metab Syndr Relat Disord,2020,18(4):206-211.

    [23]

    Taskesen T,Sekhon H,Wroblewski I,et al.Usefulness of mean platelet volume to predict significant coronary artery disease in patients with non-ST-elevation acute coronary syndromes[J].Am J Cardiol,2017,119(2):192-196.

    [24]

    Sincer I,Gunes Y,Mansiroglu AK,et al.Association of mean platelet volume and red blood cell distribution width with coronary collateral development in stable coronary artery disease[J].Postepy Kardiol Interwencyjnej,2018,14(3):263-269.

    [25]

    Şahin I,Karabulut A,Kaya A,et al.Increased level of red cell distribution width is associated with poor coronary collateral circulation in patients with stable coronary artery disease[J].Turk Kardiyol Dern Ars,2015,43(2):123-130.

    [26]

    Lin Y,Chen X,Xu X.Utility of mean platelet volume to predict the prevalence of coronary artery disease on coronary angiography in patients with stable angina[J].Coron Artery Dis,2019,30(8):615-620.

    [27]

    Liu SL,Wu NQ,Shi HW,et al.Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease[J].Cardiovasc Diabetol,2020,19(1):36.

    [28]

    Mjelva ∅R,Svingen G,Pedersen E,et al.Fibrinogen and neopterin is associated with future myocardial infarction and total mortality in patients with stable coronary artery disease[J].Thromb Haemost,2018,118(4):778-790.

    [29]

    Ya G,Qiu Z,Tianrong P.ReIation of monocyte/high-density Iipoprotein choIesterol ratio with coronary artery disease in type 2 diabetes mellitus[J].Clin Iab,2018,64(6):901-906.

  • 加载中
计量
  • 文章访问数:  643
  • PDF下载数:  260
  • 施引文献:  0
出版历程
收稿日期:  2021-01-17

目录